La Rosa Holdings reports 17% revenue growth to $68.5 million
La Rosa Holdings Corp. (NASDAQ: LRHC) reported total revenue of $68.5 million for fiscal year 2025, representing a 17% increase from $58.7 million in the prior year, according to a press release statement.
The real estate and PropTech company's residential real estate services segment drove the growth, generating $66.5 million in revenue, up $9.5 million or 17% from 2024. Other business segments also posted gains, with title settlement and insurance revenue increasing 259% to $298,000, commercial real estate brokerage services rising 112% to $694,000, and property management revenue growing 13% to $395,000.
Gross profit increased to $7.0 million from $6.0 million in the previous year, maintaining the same 17% growth rate as total revenue. The company's unrestricted cash position improved to $3.1 million as of December 31, 2025, compared to $1.4 million a year earlier.
The company reported a net loss attributable to common stockholders of $32.8 million for 2025, compared to a loss of $15.9 million in 2024. Operating expenses totaled $27.3 million, including $6.9 million in goodwill and intangible asset impairments.
La Rosa announced it signed a non-binding letter of intent to acquire Consensus Core Technologies, an AI and high-performance computing infrastructure provider. The transaction remains subject to definitive agreements, corporate approval, and customary closing conditions.
The company operates 23 corporate-owned brokerage offices across Florida, California, Texas, Georgia, and Puerto Rico, along with five franchised offices and three affiliated brokerage locations. La Rosa's auditors included a going concern qualification in their audit report, and management identified material weaknesses in internal controls over financial reporting.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Z Squared raises $15.3M in equity to fund AI infrastructure push
- FDA selects seven participants for precheck pilot program to advance U.S. drug manufacturing
- Contango settles $18.75M Lucky Shot obligations for $6.57M
Create E-mail Alert Related Categories
Corporate NewsRelated Entities
Dividend, Earnings, Definitive Agreement, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share